OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Aplasia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,971 reports · 108 co-occurring drugs

As of the last recalculation, Aplasia appears in 1,971 FAERS reports alongside 108 co-occurring drug terms. The strongest observed disproportionality signal is CYTARABINE (PRR 61.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Cytarabine29661.061.3
Aprepitant8651.451.6
Mesna Injection3646.847.0
Mesna3646.046.2
Fosaprepitant Dimeglumine5845.946.1
Ifosfamide8543.643.8
Thiotepa3640.540.7
Pegaspargase4438.838.9
Etoposide22536.436.5
Fludarabine Phosphate11733.333.4
Melphalan6330.230.3
Dimenhydrinate3030.230.3
Melphalan Hydrochloride6628.728.8
Busulfan3624.624.6
Filgrastim8324.324.3
Pemetrexed Disodium8123.423.4
Vincristine Sulfate6122.722.7
Posaconazole3221.121.2
Sulfamethoxazole And Trimethoprim15621.121.2
Cyclophosphamide Injection, Solution29320.420.4
Cyclophosphamide29320.420.4
Cyclophosphamide For Injection29320.420.4
Amphotericin B2218.718.8
Azacitidine For3118.318.3
Amikacin2817.617.6
Micafungin Sodium1417.617.6
Bleomycin Sulfate1717.517.5
Axicabtagene Ciloleucel1516.216.2
Bendamustine Hcl2315.815.9
Anti-Thymocyte Globulin (Rabbit)1215.815.8
Mercaptopurine2515.415.4
Azacitidine4215.315.3
Piperacillin And Tazobactam1815.015.0
Piperacillin Sodium,Tazobactam Sodium3614.614.6
Bendamustine Hydrochloride1614.214.2
Voriconazole4014.214.2
Doxorubicin11314.114.2
Ampicillin1114.114.1
Ampicillin Sodium1114.114.1
Cisplatin9413.313.3
Valacyclovir5013.013.0
Imatinib2112.712.7
Meropenem3712.412.4
Vancomycin6512.212.3
Carboplatin13612.112.1
Pemetrexed2412.012.0
Methylprednisolone Acetate911.911.9
Vancomycin Hydrochloride7111.811.8
Doxorubicin Hydrochloride3411.211.2
Leucovorin Calcium2011.211.2
Fluconazole7010.910.9
Posaconazole Delayed-Release1110.610.6
Cefepime1410.410.4
Ondansetron989.99.9
Ondansetron Tablets989.99.9
Piperacillin Sodium And Tazobactam Sodium189.89.8
Cyclosporine949.39.3
Brentuximab Vedotin99.39.3
Ondansetron Hydrochloride1039.39.3
Cefepime Hydrochloride149.29.2
Atropine79.09.0
Valacyclovir Hydrochloride588.98.9
Linezolid248.68.6
Dexamethasone 1.5 Mg2088.38.3
Dexamethasone2088.28.2
Granisetron Hydrochloride88.18.1
Fluorouracil Cream, 0.5%578.18.1
Granisetron88.18.1
Metoclopramide418.08.0
Fluorouracil578.08.0
Venetoclax457.97.9
Polyethylene Glycol87.87.8
Hydroxyurea157.57.5
Daratumumab277.27.2
Tranexamic Acid67.17.1
Ganciclovir Sodium77.07.0
Oxaliplatin487.07.0
Voriconazole Injection146.86.9
Ursosiol126.66.6
Carfilzomib176.46.4
Febuxostat Tablets 40 Mg66.26.2
Febuxostat Tablets 80 Mg66.26.2
Blinatumomab66.16.1
Miconazole Nitrate56.16.1
Atazanavir85.95.9
Levetiracetam In Sodium Chloride425.85.8
Levetiracetam Oral425.85.8
Levetiracetam Injection425.85.8
Imatinib Mesylate155.75.7
Alteplase85.65.6
Nilotinib155.45.4
Bortezomib445.35.3
Docetaxel Anhydrous325.15.1
Docetaxel325.15.1
Thalidomide174.94.9
Paclitaxel (Aibumin-Bound)354.64.6
Pegfilgrastim404.34.3
Gemcitabine164.34.3
Romiplostim64.24.2
Eculizumab214.14.1
Rifaximin84.04.0
Cetuximab103.43.4
Panitumumab53.43.4
Irinotecan Hydrochloride43.33.3
Polatuzumab Vedotin33.23.3
Eltrombopag Olamine73.23.2
Fam-Trastuzumab Deruxtecan-Nxki33.13.1
Sofosbuvir52.72.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.